Bioluminescence Imaging and X-ray: Why Anatomical Context Matters in Preclinical Research
Preclinical bioluminescence imaging, a form of optical imaging, has transformed research.
This article is written for researchers who rely on bioluminescence imaging inoncology, metastasis, and infectious disease models, it explores how combining bioluminescence with X-ray imaging helps overcome one of the main challenges of optical imaging: precisely locating the source of a signal within the body.
It offers extraordinary sensitivity, low background, and the ability to monitor biological processes in vivo, non-invasively, over time. For many applications, it remains the gold standard for tracking tumor growth, metastasis formation, infectious disease progression, and therapeutic response.
Yet bioluminescence has an inherent limitation. It reveals biological activity, but it provides little information about anatomy.
Researchers can easily determine that a signal exists. Determining precisely where that signal originates is often much more difficult.